We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.02B
1-Year Est. Return
53.92%
This Fund
S&P 500
This Quarter
Est. Return
-15.33%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$1.87B
AUM Growth
-$449M
(-19%)
Cap. Flow
-$58.7M
Cap. Flow
% of AUM
-3.14%
Top 10 Holdings %
Top 10 Hldgs %
33.16%
Holding
358
New
37
Increased
55
Reduced
86
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$48.3M |
| 2 |
UnitedHealth
UNH
|
+$32.7M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$19.2M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17.8M |
| 5 |
CME Group
CME
|
+$15.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$39.5M |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$26.5M |
| 3 |
Freeport-McMoran
FCX
|
+$17.7M |
| 4 |
MRO
Marathon Oil Corporation
MRO
|
+$17.1M |
| 5 |
Regal Rexnord
RRX
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.33% |
| 2 | Healthcare | 15.76% |
| 3 | Consumer Discretionary | 13.02% |
| 4 | Financials | 12.7% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Grocery Outlet
GO
$904M
| $6.78M | 0.36% |
159,140
+15,440
| +11% | +$564K |
|
52
The Ensign Group
ENSG
$10.6B
| $6.78M | 0.36% |
92,230
-4,090
| -4% | -$326K |
|
53
Amphastar Pharmaceuticals
AMPH
$905M
| $6.7M | 0.36% |
+192,649
| New | +$6.87M |
|
54
EXL Service
EXLS
$5.5B
| $6.61M | 0.35% |
+224,250
| New | +$6.34M |
|
|
AQUA
55
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $6.58M | 0.35% |
202,240
+48,020
| +31% | +$1.83M |
|
|
EFOR
56
Everforth Inc
EFOR
$962M
| $6.49M | 0.35% |
71,895
-41,430
| -37% | -$4.25M |
|
57
Calix
CALX
$2.23B
| $6.48M | 0.35% |
+189,680
| New | +$7.05M |
|
58
First Interstate BancSystem
FIBK
$3.66B
| $6.4M | 0.34% |
167,826
| – | – |
|
59
Mercury Systems
MRCY
$5.42B
| $6.36M | 0.34% |
98,910
+45,040
| +84% | +$2.69M |
|
60
Ollie's Bargain Outlet
OLLI
$4.31B
| $6.32M | 0.34% |
+107,580
| New | +$5.44M |
|
61
iShares MSCI ACWI ex US ETF
ACWX
$11.2B
| $6.29M | 0.34% |
139,850
| – | – |
|
62
ATI
ATI
$24.3B
| $6.19M | 0.33% |
272,750
-12,010
| -4% | -$317K |
|
63
Inspire Medical Systems
INSP
$1.47B
| $6.19M | 0.33% |
33,870
+4,430
| +15% | +$883K |
|
|
RCM
64
DELISTED
R1 RCM Inc. Common Stock
RCM
| $6.11M | 0.33% |
291,530
+31,300
| +12% | +$710K |
|
65
Zurn Elkay Water Solutions
ZWS
$8.61B
| $6.07M | 0.32% |
222,790
+51,960
| +30% | +$1.58M |
|
66
Gentherm
THRM
$1.31B
| $6.04M | 0.32% |
96,700
-2,589
| -3% | -$174K |
|
67
Cytokinetics
CYTK
$10.6B
| $6.01M | 0.32% |
152,855
-24,620
| -14% | -$991K |
|
68
United Therapeutics
UTHR
$26.1B
| $5.97M | 0.32% |
+25,350
| New | +$5.15M |
|
69
Bumble
BMBL
$386M
| $5.88M | 0.31% |
+208,830
| New | +$5.67M |
|
70
Lantheus
LNTH
$6.51B
| $5.86M | 0.31% |
88,680
+46,730
| +111% | +$2.95M |
|
71
Aecom
ACM
$9.44B
| $5.77M | 0.31% |
88,430
+61,810
| +232% | +$4.32M |
|
72
Mattel
MAT
$4.47B
| $5.76M | 0.31% |
257,950
-11,500
| -4% | -$272K |
|
73
MaxLinear
MXL
$5.19B
| $5.76M | 0.31% |
169,382
+25,805
| +18% | +$1.08M |
|
74
LivaNova
LIVN
$4.47B
| $5.74M | 0.31% |
91,855
-4,005
| -4% | -$284K |
|
|
GTLS
75
DELISTED
Chart Industries
GTLS
| $5.73M | 0.31% |
34,245
-1,330
| -4% | -$227K |
|
Similar funds
MCM
JIC
CFM
SM
TAM
KIA
BGDI
Castleark Management's Q2 2022 Portfolio in Review
As of Q2 2022, Castleark Management held 358 positions worth $1.87B, down 19% from $2.32B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Castleark Management withdrew a net $58.7M in Q2 2022, closing 52 positions and reducing 86 holdings. Its most notable exit was State Street Materials Select Sector SPDR ETF, an estimated $26.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Castleark Management opened a new position in State Street SPDR S&P Biotech ETF worth $47.8M.
- Castleark Management's largest Q2 2022 buy was State Street SPDR S&P Biotech ETF: 643,890 shares worth $47.8M.
- Castleark Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $17.8M increase.
- Castleark Management's biggest Q2 2022 reduction was Microchip Technology, cutting an estimated $39.5M.
- Castleark Management fully exited State Street Materials Select Sector SPDR ETF in Q2 2022, selling an estimated $26.5M.
- Castleark Management's ten largest holdings make up 33% of its $1.87B portfolio in Q2 2022.
- Castleark Management opened 37 new positions and closed 52 in Q2 2022.
- Castleark Management's portfolio value fell 19% quarter-over-quarter to $1.87B.
Based on Castleark Management's 13F filing for Q2 2022, filed 16 Aug 2022.